MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis.

Axel Benner, Larry Mansouri, Davide Rossi, Aneela Majid, Kerstin Willander, Anton Parker, Gareth Bond, Sarka Pavlova, Holger Nückel, Olaf Merkel, Paolo Ghia, Emili Montserrat, Mohd Arifin Kaderi, Richard Rosenquist, Gianluca Gaidano, Martin J S Dyer, Peter Söderkvist, Mats Linderholm, David Oscier, Zuzana TvaruzkovaSarka Pospisilova, Ulrich Dührsen, Richard Greil (Co-author), Hartmut Döhner, Stephan Stilgenbauer, Thorsten Zenz

Research output: Contribution to journalOriginal Articlepeer-review

3 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1285-1291
JournalHAEMATOLOGICA
Volume99
Issue number8
DOIs
Publication statusPublished - 2014

Keywords

  • SINGLE NUCLEOTIDE POLYMORPHISM
  • P53 PATHWAY
  • SNP309
  • RISK
  • SUSCEPTIBILITY
  • EXPRESSION
  • INHIBITORS
  • SURVIVAL
  • GENE
  • CLL

Cite this